Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

3rd Annual CKD3, March 2-4 2021

Conferences
Welcome to the 3rd Annual Gathering of Chronic Kidney Disease Drug Developers: CKD3. Overcome the translational challenges limiting the development of the next generation of CKD therapeutics.

For the 3rd year, the chronic Kidney Disease Drug Development Summit (CKD3) is putting the hottest topics in CKD drug development under the spotlight. Across 3 days of content, the world-class faculty will address questons including: what is the drug development opportunity beyond current standards of care including SGLT-2 and GLP-1, how is pharma harnessing the power of AI and what kidney organoids are providing innovation to target identification? CKD3 is the definitive, intimately focused forum promoting cross stakeholder discussion and networking to accelerate the next line of CKD drugs.

A selection of speakers: Maria Gomez LUDC, Matthias Kretzler University of Michigan, Jeremy Duffield Vertex Pharmaceuticals, Jyothis George Novo Nordisk, Uptal Patel Gilead, Aliza Thompson FDA.

PDF icon Link to flyer

Link to webb page

 

 

Time: 
2 March 2021 08:00 to 4 March 2021 16:00
Location: 
Digitally

About the event

Time: 
2 March 2021 08:00 to 4 March 2021 16:00
Location: 
Digitally

Lund University Diabetes Centre, CRC, SUS Malmö, Jan Waldenströms gata 35, House 91:12. SE-214 28 Malmö. Telephone: +46 40 39 10 00